| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/11/1999 | WO1999006441A1 Proteinic product, process for its preparation, compositions containing it and use in medicaments |
| 02/11/1999 | WO1999006440A1 Novel synthetic peptides with antimicrobial and endotoxin neutralizing properties for management of the sepsis syndrome |
| 02/11/1999 | WO1999006439A2 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN ENDODERM |
| 02/11/1999 | WO1999006438A2 Compounds with anti-ks and anti-hiv activity |
| 02/11/1999 | WO1999006437A1 Sulfonylated dipeptide compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | WO1999006436A1 Benzyl compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | WO1999006435A1 Dipeptide compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | WO1999006434A1 4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | WO1999006433A1 Compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | WO1999006432A1 Dipeptide and related compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | WO1999006431A1 Substituted phenylalanine type compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | WO1999006430A1 Alatrofloxacin parenteral compositions |
| 02/11/1999 | WO1999006429A1 Method for stabilizing useful proteins and useful protein compositions |
| 02/11/1999 | WO1999006428A1 Tango-72 and tango-77 nucleic acid molecules and polypeptides |
| 02/11/1999 | WO1999006427A1 Tango-78, tango-79, and tango-81 nucleic acid molecules and polypeptides |
| 02/11/1999 | WO1999006426A1 Novel molecules of the tango-77 related protein family and uses thereof |
| 02/11/1999 | WO1999006423A1 83 human secreted proteins |
| 02/11/1999 | WO1999006391A1 Alpha-9 integrin antagonists and anti-inflammatory compositions therof |
| 02/11/1999 | WO1999006390A1 Carbamyloxy compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | WO1999006073A1 Method for the treatment of grafts |
| 02/11/1999 | WO1999006067A1 Method of removing endotoxin from vaccines |
| 02/11/1999 | WO1999006066A2 Catalytic monoclonal antibodies with protease activity for the selective lysis of the protein component of plaques and aggregates related to pathological conditions |
| 02/11/1999 | WO1999006065A1 Aqueous preparation of lactoferrin having improved stability |
| 02/11/1999 | WO1999006064A1 Method for preventing and treating hearing loss using a neurturin protein product |
| 02/11/1999 | WO1999006063A1 EPO PRIMARY RESPONSE GENE, EPRG3pt |
| 02/11/1999 | WO1999006062A1 Cyclic peptide antifungal agents |
| 02/11/1999 | WO1999006061A1 Prediction, detection, and design of t cell epitopes |
| 02/11/1999 | WO1999006060A1 Methods for treating neurological deficits |
| 02/11/1999 | WO1999006059A2 Methods and compositions relating to no-mediated cytotoxicity |
| 02/11/1999 | WO1999006054A1 Wound and injury treatment compositions and the use thereof |
| 02/11/1999 | WO1999006034A1 Coup-tfi directed therapies in the treatment of disease |
| 02/11/1999 | WO1999006026A1 Stable particulate complexes with neutral or negative global charge of lamellar structure |
| 02/11/1999 | WO1999006023A1 Ophthalmic compositions containing galactomannan polymers and borate |
| 02/11/1999 | WO1999006022A1 Artificial tear formulation |
| 02/11/1999 | WO1999005911A1 A method for modulation of circadian rhythmicity |
| 02/11/1999 | WO1998050057A3 Agent for enhancing the heart force |
| 02/11/1999 | WO1998049324A3 Carbohydrate-deficient glycoprotein syndrome type i |
| 02/11/1999 | WO1998049311A3 Ricin-like toxin variants for treatment of cancer, viral or parasitic infections |
| 02/11/1999 | WO1998049194A3 Ras-like protein |
| 02/11/1999 | WO1998046771A3 Highly purified mocarhagin, a cobra venom protease, polynucleotides encoding same, related proteases, and therapeutic uses thereof |
| 02/11/1999 | WO1998044948A3 Intravenous immune globulin formulation containing a non-ionic surface active agent with improved pharmacokinetic properties |
| 02/11/1999 | WO1998040474A3 Activated vitamin k-dependent blood factor and method for the production thereof |
| 02/11/1999 | WO1998035032A3 Methods of inducing cell cycle stasis |
| 02/11/1999 | WO1998030239A3 Process for preparing conjugate vaccines including free protein and the conjugate vaccines, immunogens, and immunogenic reagents produced by this procedure |
| 02/11/1999 | DE19734293A1 Verwendung von pharmazeutischen Kombinationspräparaten enthaltend Erythropoietin und Eisenpräparate zur Behandlung von rheumatischen Erkrankungen Use of pharmaceutical combination preparations comprising erythropoietin and iron preparations for the treatment of rheumatic diseases |
| 02/11/1999 | DE19729591A1 Mittel zur Behandlung und/oder Prophylaxe von Mikrozirkulationsstörungen Agents for the treatment and / or prophylaxis of microcirculation disorders |
| 02/11/1999 | DE19728737C1 Verfahren zur Erkennung und Bestimmung von GnRH-Rezeptoren und die Verwendung von GnRH-Agonisten und GnRH-Antagonisten zur Behandlung eines Tumors ausgehend vom Hirn und/oder Nervensystem und/oder den Hirnhäuten A method for the detection and determination of GnRH receptors and the use of GnRH agonists and GnRH-antagonists for the treatment of a tumor originating in the brain and / or nervous system and / or the meninges |
| 02/11/1999 | DE19725803C1 HBV-gerichtete Antisense-Nukleinsäuren HBV-directed antisense nucleic acids |
| 02/11/1999 | CA2301184A1 Cyclic peptide antifungal agents |
| 02/11/1999 | CA2299623A1 Catalytic monoclonal antibodies for the in vivo transformation of corticosteroid prodrugs |
| 02/11/1999 | CA2299620A1 Antifreeze proteins, dna and expression systems |
| 02/11/1999 | CA2299276A1 Tango-78, tango-79, and tango-81 nucleic acid molecules and polypeptides |
| 02/11/1999 | CA2299256A1 Tango-72 and tango-77 nucleic acid molecules and polypeptides |
| 02/11/1999 | CA2299055A1 Novel molecules of the tango-77 related protein family and uses thereof |
| 02/11/1999 | CA2299054A1 Compounds with anti-ks and anti-hiv activity |
| 02/11/1999 | CA2298852A1 83 human secreted proteins |
| 02/11/1999 | CA2298811A1 Method for the treatment of grafts |
| 02/11/1999 | CA2298766A1 Human longevity-assurance protein homologs |
| 02/11/1999 | CA2298573A1 Synaptojanin isoform |
| 02/11/1999 | CA2298506A1 Methods for treating neurological deficits |
| 02/11/1999 | CA2298115A1 Inhibitors of cell-cycle progression and uses related thereto |
| 02/11/1999 | CA2298101A1 Novel synthetic peptides with antimicrobial and endotoxin neutralizing properties for management of the sepsis syndrome |
| 02/11/1999 | CA2298062A1 Genetic and protein therapy products for treating cystic fibrosis and inducing a glutathione-s-transferase function |
| 02/11/1999 | CA2297490A1 Method enabling readministration of aav vector via immunosuppression of host |
| 02/11/1999 | CA2297489A1 Novel bone mineralization proteins, dna, vectors, expression systems |
| 02/11/1999 | CA2297157A1 5' ests for secreted proteins expressed in testis and other tissues |
| 02/11/1999 | CA2297109A1 5' ests for secreted proteins expressed in muscle and other mesodermal tissues |
| 02/11/1999 | CA2296809A1 5' ests for secreted proteins identified from brain tissues |
| 02/11/1999 | CA2296398A1 5' ests for secreted proteins expressed in endoderm |
| 02/11/1999 | CA2296394A1 Stable particulate complexes with neutral or negative global charge of lamellar structure |
| 02/11/1999 | CA2291475A1 Dipeptide compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | CA2291473A1 Benzyl compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | CA2290750A1 4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | CA2290749A1 Dipeptide and related compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | CA2290748A1 Sulfonylated dipeptide compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | CA2290747A1 Substituted phenylalanine type compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | CA2290746A1 Compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | CA2244801A1 Suppressory agents against hypercoagulation |
| 02/11/1999 | CA2239836A1 Novel arginine deiminase |
| 02/11/1999 | CA2239813A1 Novel nrdd |
| 02/11/1999 | CA2239221A1 Novel his5 |
| 02/11/1999 | CA2225185A1 Myoblast transfer therapy for relieving pain and for treating behavioral and perceptive abnormalities |
| 02/10/1999 | EP0896061A2 RpoA gene from Staphylococcus aureus |
| 02/10/1999 | EP0896060A2 RpoA gene from Staphylococcus aureus |
| 02/10/1999 | EP0896059A2 Method for the production of pathogen resistant plants |
| 02/10/1999 | EP0896058A1 Novel semaphorin z and gene encoding the same |
| 02/10/1999 | EP0896055A2 Apoptosis inducing protein and gene encoding the same |
| 02/10/1999 | EP0896003A1 Peptides for reducing or inhibiting bone resorption, angiogenesis and restenosis |
| 02/10/1999 | EP0896002A1 Chimeric proteins, heterodimer complexes thereof and substitute for platelet |
| 02/10/1999 | EP0896000A1 Process for isolation of 1-[N2-((S-Ethoxycarbonyl)-3-phenylpropyl)-N6-trifluoroacetyl]-L-lysyl-L-proline (Lisinopril (Tfa) ethylester, LPE) |
| 02/10/1999 | EP0895545A1 Novel protein - traf6 |
| 02/10/1999 | EP0895543A1 Method of stimulating an immune response by administration of host organisms that express intimin alone or as a fusion protein with one or more other antigens |
| 02/10/1999 | EP0895539A2 Secreted proteins and polynucleotides encoding them |
| 02/10/1999 | EP0895534A1 Compositions containing bacteriophages and methods of using bacteriophages to treat infections |
| 02/10/1999 | EP0895479A1 Diabetes treatment |
| 02/10/1999 | EP0895478A1 Component b as cicatrizant |
| 02/10/1999 | EP0895474A1 Liquid eye drop composition |
| 02/10/1999 | EP0895473A1 Polysaccharide microspheres for the pulmonary delivery of drugs |
| 02/10/1999 | EP0787008A4 Method for treating secondary immunodeficiency |
| 02/10/1999 | EP0777746A4 Assay for the detection of proteases |